Veterinary Medicines

ADENIPRAVAC-ND/IB/EDS 76 ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ

Not authorised
  • Eggdrop syndrome-1976 virus, Inactivated
  • Newcastle disease virus, strain La Sota, Inactivated
  • Avian infectious bronchitis virus, strain H52, Inactivated
Download as PDF

Product identification

Medicine name:
ADENIPRAVAC-ND/IB/EDS 76 ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ
Active substance:
  • Eggdrop syndrome-1976 virus, Inactivated
  • Newcastle disease virus, strain La Sota, Inactivated
  • Avian infectious bronchitis virus, strain H52, Inactivated
Target species:
  • Poultry
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Eggdrop syndrome-1976 virus, Inactivated
    100000000.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
  • Newcastle disease virus, strain La Sota, Inactivated
    1000000000.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, strain H52, Inactivated
    100000000.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Poultry
      • Meat and offal
        21
        day
  • Subcutaneous use
    • Poultry
      • Meat and offal
        21
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA13
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 12616/95/K-2709/03-04-1995/K-0099501
Date of authorisation status change: